FDA Approved: JUBLIA — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for JUBLIA (efinaconazole) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• JUBLIA (efinaconazole)

Snippet

SUPPL AP for JUBLIA (EFINACONAZOLE)